Takeda Announces Candidates for New Directors

April 13, 2017

Osaka, Japan, April 13, 2017 – Takeda Pharmaceutical Company Limited (TSE 4502) today announced that it has decided the candidates for new Directors which will be proposed to the 141st Ordinary General Meeting of Shareholders on June, 2017. The candidates are as follows;

1. Candidates for Non-Audit and Supervisory Committee Director

Name

Category

Current Role

Christophe Weber

Internal

Existing

Representative Director,
President & Chief Executive Officer

Masato Iwasaki

Internal

Existing

Director, President, Japan Pharma Business Unit

James Kehoe

Internal

New

Corporate Officer, Chief Financial Officer

Andrew Plump

Internal

Existing

Director, Chief Medical & Scientific Officer

Yoshiaki Fujimori

External

Existing

External Director

Emiko Higashi

External

Existing

External Director

Michel Orsinger

External

Existing

External Director

Masahiro Sakane

External

Existing

External Director

Toshiyuki Shiga

External

Existing

External Director


2. Candidates for Audit and Supervisory Committee Directors 
Audit and Supervisory Committee Directors (Yasuhiko Yamanaka, Shiro Kuniya, Koji Hatsukawa and Jean-Luc Butel) are within their 2-year tenure, and are not subjects for reelection this year.

3. Directors who will retire

Name

Category

Current Role

Yasuchika Hasegawa

Internal

Director, Chairman of the Board

Shinji Honda

Internal

Director, Corporate Strategy Officer

Fumio Sudo

External

External Director


Yasuchika Hasegawa will be appointed as Corporate Counselor upon the company request after retiring from Chairman of the Board. 

While we will not appoint a successor to Chairman Hasegawa on this occasion, Masahiro Sakane, who has been an External Director of Takeda since 2014, has kindly accepted to chair the board meeting after the General Meeting of Shareholders in June.

 # # #

Media Contact
Tsuyoshi Tada
Tel: +81-3-3278-2417
Email: tsuyoshi.tada@takeda.com